These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 20798478)

  • 1. Comparison of multiple steroid concentrations in serum and dried blood spots throughout the day of patients with congenital adrenal hyperplasia.
    Sarafoglou K; Himes JH; Lacey JM; Netzel BC; Singh RJ; Matern D
    Horm Res Paediatr; 2011; 75(1):19-25. PubMed ID: 20798478
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Monitoring steroid replacement therapy in children with congenital adrenal hyperplasia.
    Birkebaek NH; Hougaard DM; Cohen AS
    J Pediatr Endocrinol Metab; 2017 Jan; 30(1):85-88. PubMed ID: 27977405
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Serum cortisol and 17-hydroxyprogesterone interrelation in classic 21-hydroxylase deficiency: is current replacement therapy satisfactory?
    Charmandari E; Matthews DR; Johnston A; Brook CG; Hindmarsh PC
    J Clin Endocrinol Metab; 2001 Oct; 86(10):4679-85. PubMed ID: 11600525
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Scalp hair 17-hydroxyprogesterone and androstenedione as a long-term therapy monitoring tool in congenital adrenal hyperplasia.
    Noppe G; de Rijke YB; Koper JW; van Rossum EF; van den Akker EL
    Clin Endocrinol (Oxf); 2016 Oct; 85(4):522-7. PubMed ID: 27061431
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dynamics of 24-hour pulsatile cortisol, 17-hydroxyprogesterone, and androstenedione release in prepubertal patients with nonclassic 21-hydroxylase deficiency and normal prepubertal children.
    Ghizzoni L; Bernasconi S; Virdis R; Vottero A; Ziveri M; Volta C; Iughetti L; Giovannelli G
    Metabolism; 1994 Mar; 43(3):372-7. PubMed ID: 8139487
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Steroid profile in dried blood spots by liquid chromatography tandem mass spectrometry: Application to newborn screening for congenital adrenal hyperplasia in China.
    Zhan X; Han L; Qiu W; Gu X; Guo J; Chang S; Wang Y; Zhang H
    Steroids; 2022 Sep; 185():109056. PubMed ID: 35660382
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacokinetic/Pharmacodynamic Evaluation of Hydrocortisone Therapy in Pediatric Patients with Congenital Adrenal Hyperplasia.
    Melin J; Parra-Guillen ZP; Michelet R; Truong T; Huisinga W; Hartung N; Hindmarsh P; Kloft C
    J Clin Endocrinol Metab; 2020 Mar; 105(3):. PubMed ID: 32052005
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Correlation between androstenedione and 17-hydroxyprogesterone levels in the saliva and plasma of patients with congenital adrenal hyperplasia.
    Juniarto AZ; Goossens K; Setyawati BA; Drop SL; de Jong FH; Faradz SM
    Singapore Med J; 2011 Nov; 52(11):810-3. PubMed ID: 22173250
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Simultaneous quantification of 17α-OH progesterone, 11-deoxycortisol, Δ4-androstenedione, cortisol and cortisone in newborn blood spots using liquid chromatography-tandem mass spectrometry.
    Magnisali P; Chalioti MB; Livadara T; Mataragas M; Paliatsiou S; Malamitsi-Puchner A; Moutsatsou P
    J Chromatogr B Analyt Technol Biomed Life Sci; 2011 Jun; 879(19):1565-72. PubMed ID: 21514253
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Newborn screening for congenital adrenal hyperplasia: additional steroid profile using liquid chromatography-tandem mass spectrometry.
    Janzen N; Peter M; Sander S; Steuerwald U; Terhardt M; Holtkamp U; Sander J
    J Clin Endocrinol Metab; 2007 Jul; 92(7):2581-9. PubMed ID: 17456574
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Steroid profiling for congenital adrenal hyperplasia by tandem mass spectrometry as a second-tier test reduces follow-up burdens in a tertiary care hospital: a retrospective and prospective evaluation.
    Seo JY; Park HD; Kim JW; Oh HJ; Yang JS; Chang YS; Park WS; Lee SY
    J Perinat Med; 2014 Jan; 42(1):121-7. PubMed ID: 23989111
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Determination of serum steroids in monitoring therapy of congenital adrenal hyperplasia].
    Xiao HW; Ma HM; Su Z; Du ML; Li YH; Chen HS; Chen QL
    Zhonghua Er Ke Za Zhi; 2012 Apr; 50(4):301-7. PubMed ID: 22801236
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Therapy monitoring in congenital adrenal hyperplasia by dried blood samples.
    Wieacker I; Peter M; Borucki K; Empting S; Roehl FW; Mohnike K
    J Pediatr Endocrinol Metab; 2015 Jul; 28(7-8):867-71. PubMed ID: 25781526
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Improved specificity of newborn screening for congenital adrenal hyperplasia by second-tier steroid profiling using tandem mass spectrometry.
    Lacey JM; Minutti CZ; Magera MJ; Tauscher AL; Casetta B; McCann M; Lymp J; Hahn SH; Rinaldo P; Matern D
    Clin Chem; 2004 Mar; 50(3):621-5. PubMed ID: 14656905
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Development and evaluation of a candidate reference measurement procedure for detecting 17α-hydroxyprogesterone in dried blood spots using isotope dilution liquid chromatography tandem mass spectrometry.
    He Z; Dai H; Shen J; Huang Y; Liu J; Yan R; Zhang F; Yan S
    Anal Bioanal Chem; 2024 Aug; 416(20):4635-4645. PubMed ID: 38949681
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Steroid 17-Hydroxyprogesterone in Hair Is a Potential Long-Term Biomarker of Androgen Control in Congenital Adrenal Hyperplasia due to 21-Hydroxylase Deficiency.
    Auer MK; Krumbholz A; Bidlingmaier M; Thieme D; Reisch N
    Neuroendocrinology; 2020; 110(11-12):938-949. PubMed ID: 31711056
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Salivary 17-hydroxyprogesterone concentration in monitoring of the treatment of congenital adrenal hyperplasia].
    Arisaka O; Shimura N; Nakayama Y; Arisaka M; Yabuta K
    Dtsch Med Wochenschr; 1988 Dec; 113(49):1913-5. PubMed ID: 3197614
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hormonal disturbances due to severe and mild forms of congenital adrenal hyperplasia are already detectable in neonatal life.
    Faurschou S; Mouritsen A; Johannsen TH; Hougaard DM; Cohen A; Duno M; Juul A; Main KM
    Acta Paediatr; 2015 Feb; 104(2):e57-62. PubMed ID: 25346389
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The hypothalamic-pituitary-adrenal axis in partial (late-onset) 21-hydroxylase deficiency.
    Feuillan P; Pang S; Schürmeyer T; Avgerinos PC; Chrousos GP
    J Clin Endocrinol Metab; 1988 Jul; 67(1):154-60. PubMed ID: 2837498
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Reverse circadian glucocorticoid treatment in prepubertal children with congenital adrenal hyperplasia.
    Dubinski I; Bechtold Dalla-Pozza S; Bidlingmaier M; Reisch N; Schmidt H
    J Pediatr Endocrinol Metab; 2021 Dec; 34(12):1543-1548. PubMed ID: 34523293
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.